Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They ...

The Food and Drug Administration approved a higher-dose version of a popular class of obesity drugs on Thursday, the latest ...

Within hours of the semaglutide patent expiry, a host of Indian pharma companies have rolled out weight-loss drugs at affordable prices, ensuring that cost is no longer a barrier ...

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...

Use of prescription weight-loss drugs like Wegovy and Mounjaro may be reaching new highs, but most Americans who haven't ...

Lilly’s momentum isn’t just about its successful clinical results, though. It’s also about the company’s constant iteration ...

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or ...

Let's dive in.

SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting ...

Multiple GLP-1 injection pens. GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is ...

A newly reported side effect of the popular GLP-1 weight loss drugs may be its most annoying yet. From “Ozempic ears” and ...

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest ...